Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
Clinical trial NCT00841373 · COMPLETED
Trial details
- NCT number
- NCT00841373
- Sponsor
- Southern New England Retina Associates
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2009-01-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.